1. Home
  2. Analysis
  3. Q10
  4. Piqray

Q10 and Piqray drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Q10 (coenzyme q - 10) and Piqray (alpelisib). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Q10 and Piqray. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Q10?

Q10 has active ingredients of coenzyme q - 10. eHealthMe is studying from 34,261 Q10 users. Check the latest studies of Q10.

What is Piqray?

Piqray has active ingredients of alpelisib. eHealthMe is studying from 7,290 Piqray users. Check the latest studies of Piqray.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

11 people who take Q10 and Piqray together, and have interactions are studied.

Q10 and Piqray drug interactions.

What are the common drug interactions of Q10 and Piqray, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Asthenia (weakness)
  3. Oral herpes (viral infection of mouth)
  4. Pain
  5. Skin discolouration (change of skin colour)
  6. Skin exfoliation (removal of the oldest dead skin cells)
  7. Skin reaction
  8. Trigger finger
  9. Tumour marker increased
  10. Death

male:

n/a

What are the common drug interactions of Q10 and Piqray, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Hyperglycaemia (high blood sugar)

60+:

  1. Asthenia (weakness)
  2. Blood glucose increased
  3. Oral herpes (viral infection of mouth)
  4. Pain
  5. Skin discolouration (change of skin colour)
  6. Skin exfoliation (removal of the oldest dead skin cells)
  7. Skin reaction
  8. Trigger finger
  9. Tumour marker increased
  10. Death

What are the existing conditions these people have? *

  1. Breast Cancer Female: 4 people, 36.36%
  2. Breast Cancer: 2 people, 18.18%
  3. Metastases To Bone (cancer spreads to bone): 1 person, 9.09%
  4. Malignant Lymphoid Neoplasm (malignant growth or tumour caused by abnormal and uncontrolled cell division in lymph node): 1 person, 9.09%
  5. Breast Cancer Stage Iv: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Q10 and Piqray?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Q10 and Piqray:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Q10:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Piqray:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Q10 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Piqray and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on coenzyme q - 10 and alpelisib (the active ingredients of Q10 and Piqray, respectively), and Q10 and Piqray (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.